Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
dabrafenib benzodiazepines

decreases exposure

Moderate Study
dabrafenib calciumchannelblockers

decreases exposure

Moderate Theoretical
dabrafenib everolimus

decreases concentration

Moderate Study
dabrafenib felodipine

decreases exposure

Moderate Theoretical
dabrafenib guanfacine

decreases concentration

Moderate Theoretical
dabrafenib lacidipine

decreases exposure

Moderate Theoretical
dabrafenib lercanidipine

decreases exposure

Moderate Theoretical
dabrafenib lurasidone

decreases exposure

Moderate Theoretical
dabrafenib methadone

decreases exposure

Moderate Study
dabrafenib midazolam

decreases exposure

Moderate Study
dabrafenib nicardipine

decreases exposure

Moderate Theoretical
dabrafenib nifedipine

decreases exposure

Moderate Theoretical
dabrafenib nimodipine

decreases exposure

Moderate Theoretical
dabrafenib opioids

decreases exposure

Moderate Study
dabrafenib osimertinib

decreases exposure

Moderate Study
dabrafenib ripretinib

decreases exposure

Moderate Theoretical
dabrafenib ruxolitinib

decreases exposure

Moderate Study
dacomitinib atomoxetine

increases exposure

Moderate Study
dacomitinib eliglustat

increases exposure

Moderate Study
dapsone prilocaine

increases risk of methaemoglobinaemia

Moderate Theoretical
dapsone topicalanaesthetics,local

increases risk of methaemoglobinaemia

Moderate Theoretical
dapsone topicalprilocaine

increases risk of methaemoglobinaemia

Moderate Theoretical
deferasirox treprostinil

increases exposure

Moderate Theoretical
diazepampotentially antiepileptics

affects concentration

Moderate Study
diazepampotentially fosphenytoin

affects concentration

Moderate Study
diazepampotentially phenytoin

affects concentration

Moderate Study
diazoxide antiepileptics

decreases concentration

Moderate Anecdotal
diazoxide fosphenytoin

decreases concentration

Moderate Anecdotal
diazoxide phenytoin

decreases concentration

Moderate Anecdotal
diltiazem antiepileptics

increases concentration

Moderate Anecdotal
diltiazem atorvastatin

increases exposure

Moderate Study
diltiazem carbamazepine

increases concentration

Moderate Anecdotal
diltiazem fostamatinib

increases exposure

Moderate Theoretical
diltiazem statins

increases exposure

Moderate Study
dipyridamole adenosine

increases exposure

Moderate Study
dipyridamole antiarrhythmics

increases exposure

Moderate Study
disulfiram antiepileptics

increases concentration

Moderate Study
disulfiram coumarins

increases anticoagulant effect

Moderate Study
disulfiram fosphenytoin

increases concentration

Moderate Study
disulfiram phenytoin

increases concentration

Moderate Study
dolutegravir dopaminereceptoragonists

increases exposure

Moderate Study
dolutegravir metformin

increases exposure

Moderate Study
dolutegravir pramipexole

increases exposure

Moderate Study
doravirine sirolimus

decreases exposure

Moderate Theoretical
doravirine tacrolimus

decreases exposure

Moderate Theoretical
dronedarone alfentanil

increases exposure

Moderate Study
dronedarone amlodipine

increases exposure

Moderate Study
dronedarone atorvastatin

increases exposure

Moderate Study
dronedarone bosutinib

increases exposure

Moderate Study
dronedarone buprenorphine

increases exposure

Moderate Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.